Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 160

1.

Risk factors, preemptive therapy, and antiperistaltic agents for Clostridium difficile infection in cancer patients.

Krishna SG, Zhao W, Apewokin SK, Krishna K, Chepyala P, Anaissie EJ.

Transpl Infect Dis. 2013 Oct;15(5):493-501. doi: 10.1111/tid.12112. Epub 2013 Aug 27.

PMID:
24034141
2.

Risk factors, outcomes and epidemiology associated with Clostridium difficile infection in patients with haematological malignancies in a tertiary care hospital in China.

Gu SL, Chen YB, Lv T, Zhang XW, Wei ZQ, Shen P, Li LJ.

J Med Microbiol. 2015 Mar;64(Pt 3):209-16. doi: 10.1099/jmm.0.000028. Epub 2015 Jan 16.

PMID:
25596117
3.

Clostridium difficile infection after allogeneic hematopoietic stem cell transplantation: incidence, risk factors, and outcome.

Willems L, Porcher R, Lafaurie M, Casin I, Robin M, Xhaard A, Andreoli AL, Rodriguez-Otero P, Dhedin N, Socié G, Ribaud P, Peffault de Latour R.

Biol Blood Marrow Transplant. 2012 Aug;18(8):1295-301. doi: 10.1016/j.bbmt.2012.02.010. Epub 2012 Feb 28.

4.

Epidemiology and outcomes of Clostridium difficile infections in hematopoietic stem cell transplant recipients.

Alonso CD, Treadway SB, Hanna DB, Huff CA, Neofytos D, Carroll KC, Marr KA.

Clin Infect Dis. 2012 Apr;54(8):1053-63. doi: 10.1093/cid/cir1035. Epub 2012 Mar 12.

5.

Risk factors for the development of Clostridium difficile infection in adult allogeneic hematopoietic stem cell transplant recipients: A single-center study in Québec, Canada.

Lavallée C, Labbé AC, Talbot JD, Alonso CD, Marr KA, Cohen S, Laverdière M, Dufresne SF.

Transpl Infect Dis. 2017 Feb;19(1). doi: 10.1111/tid.12648. Epub 2017 Jan 11.

PMID:
27943498
6.

Risk factors and outcome of PCR-detected Clostridium difficile infection in ileal pouch patients.

Li Y, Qian J, Queener E, Shen B.

Inflamm Bowel Dis. 2013 Feb;19(2):397-403. doi: 10.1097/MIB.0b013e318280fcb9.

PMID:
23328770
7.

Risk factors associated with Clostridium difficile infection after kidney and pancreas transplantation.

Shah SA, Tsapepas DS, Kubin CJ, Martin ST, Mohan S, Ratner LE, Pereira M, Kapur S, Dadhania D, Walker-McDermott JK.

Transpl Infect Dis. 2013 Oct;15(5):502-9. doi: 10.1111/tid.12113. Epub 2013 Jul 25.

PMID:
23890202
8.

Clostridium difficile infection in patients with acute myelogenous leukemia and in patients undergoing allogeneic stem cell transplantation: epidemiology and risk factor analysis.

Vehreschild MJ, Weitershagen D, Biehl LM, Tacke D, Waldschmidt D, Töx U, Wisplinghoff H, Von Bergwelt-Baildon M, Cornely OA, Vehreschild JJ.

Biol Blood Marrow Transplant. 2014 Jun;20(6):823-8. doi: 10.1016/j.bbmt.2014.02.022. Epub 2014 Mar 6.

9.

Clostridium difficile infection in hospitalized cancer patients in Beijing, China is facilitated by receipt of cancer chemotherapy.

Han XH, Du CX, Zhang CL, Zheng CL, Wang L, Li D, Feng Y, DuPont HL, Jiang ZD, Shi YK.

Anaerobe. 2013 Dec;24:82-4. doi: 10.1016/j.anaerobe.2013.05.004. Epub 2013 Jun 14.

PMID:
23770543
10.

Recurrence of Clostridium difficile infection among veterans with spinal cord injury and disorder.

Ramanathan S, Johnson S, Burns SP, Kralovic SM, Goldstein B, Smith B, Gerding DN, Evans CT.

Am J Infect Control. 2014 Feb;42(2):168-73. doi: 10.1016/j.ajic.2013.08.009.

PMID:
24485372
11.

Clostridium difficile infection in cancer patients and hematopoietic stem cell transplant recipients.

Chopra T, Alangaden GJ, Chandrasekar P.

Expert Rev Anti Infect Ther. 2010 Oct;8(10):1113-9. doi: 10.1586/eri.10.95. Review.

PMID:
20954878
12.

A clinical risk index for Clostridium difficile infection in hospitalised patients receiving broad-spectrum antibiotics.

Garey KW, Dao-Tran TK, Jiang ZD, Price MP, Gentry LO, Dupont HL.

J Hosp Infect. 2008 Oct;70(2):142-7. doi: 10.1016/j.jhin.2008.06.026. Epub 2008 Aug 23.

PMID:
18723249
13.

Risk factors and epidemiology of Clostridium difficile infection in hematopoietic stem cell transplant recipients during the peritransplant period.

Aldrete SD, Kraft CS, Magee MJ, Chan A, Hutcherson D, Langston AA, Greenwell BI, Burd EM, Friedman-Moraco R.

Transpl Infect Dis. 2017 Feb;19(1). doi: 10.1111/tid.12649.

PMID:
27943501
14.

Clostridium difficile colonization and disease in patients undergoing hematopoietic stem cell transplantation.

Bruminhent J, Wang ZX, Hu C, Wagner J, Sunday R, Bobik B, Hegarty S, Keith S, Alpdogan S, Carabasi M, Filicko-O'Hara J, Flomenberg N, Kasner M, Outschoorn UM, Weiss M, Flomenberg P.

Biol Blood Marrow Transplant. 2014 Sep;20(9):1329-34. doi: 10.1016/j.bbmt.2014.04.026. Epub 2014 May 2.

15.

The choice of multiple myeloma induction therapy affects the frequency and severity of oral mucositis after melphalan-based autologous stem cell transplantation.

Fleming S, Harrison SJ, Blombery P, Joyce T, Stokes K, Seymour JF, Prince HM, Ritchie D.

Clin Lymphoma Myeloma Leuk. 2014 Aug;14(4):291-6. doi: 10.1016/j.clml.2014.02.001. Epub 2014 Feb 15.

PMID:
24629850
16.

Clinical predictors of recurrent Clostridium difficile infection in out-patients.

Shivashankar R, Khanna S, Kammer PP, Scott Harmsen W, Zinsmeister AR, Baddour LM, Pardi DS.

Aliment Pharmacol Ther. 2014 Sep;40(5):518-22. doi: 10.1111/apt.12864. Epub 2014 Jul 10.

17.

Epidemiology and risk factors for Clostridium difficile infection in children.

Sandora TJ, Fung M, Flaherty K, Helsing L, Scanlon P, Potter-Bynoe G, Gidengil CA, Lee GM.

Pediatr Infect Dis J. 2011 Jul;30(7):580-4. doi: 10.1097/INF.0b013e31820bfb29.

PMID:
21233782
18.

Incidence of Clostridium difficile-associated diarrhea before and after autologous peripheral blood stem cell transplantation for lymphoma and multiple myeloma.

Arango JI, Restrepo A, Schneider DL, Callander NS, Ochoa-Bayona JL, Restrepo MI, Bradshaw P, Patterson J, Freytes CO.

Bone Marrow Transplant. 2006 Mar;37(5):517-21.

PMID:
16435018
19.

Epidemiology of suspected Clostridium difficile-associated hospital-acquired diarrhea in hospitalized patients at Siriraj Hospital.

Thipmontree W, Kiratisin P, Manatsathit S, Thamlikitkul V.

J Med Assoc Thai. 2011 Feb;94 Suppl 1:S207-16.

PMID:
21721449
20.

Clostridium difficile infection among kidney transplant recipients: frequency, clinical presentation, and outcome.

Lionaki S, Panagiotellis K, Moris D, Daikos G, Psyhogiou M, Vernadakis S, Zavos G, Boletis JN.

APMIS. 2015 Mar;123(3):234-9. doi: 10.1111/apm.12348. Epub 2014 Dec 31.

PMID:
25556694

Supplemental Content

Support Center